nephrology

Trending/nephrology

Dr. Vicente Torres

Vicente Torres, M.D., Ph.D., discusses new findings on tolvaptan as autosomal dominant polycystic kidney disease treatment

ROCHESTER, Minn. – A phase 3 trial studying the effects of tolvaptan has found that the drug slowed the rate of decline in kidney function…

Sign up